• Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

  • Jul 17 2024
  • Duración: 30 m
  • Podcast

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today  Por  arte de portada

Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

  • Resumen

  • Clinical trials have reshaped multidisciplinary treatment paradigms for early-stage disease. Is your clinic up to date?

    Credit available for this activity expires: 7/15/25
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001332?ecd=bdc_podcast_libsyn_mscpedu

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Immunotherapy for Early-Stage Resectable NSCLC: Optimizing Multidisciplinary Management Today

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.